The data to be translated: A Dutch-Swiss startup, Cradle, has recently secured $240 million in funding, leveraging generative artificial intelligence technology to assist scientists in designing and engineering proteins faster and more cost-effectively. Cradle's research and development is expected to enhance the resolution of protein engineering problems that are challenging for traditional tools, bringing innovation to the biopharmaceutical field.